LifeStance Health Group, Inc. (NASDAQ:LFST) Receives Average Rating of “Moderate Buy” from Analysts

LifeStance Health Group, Inc. (NASDAQ:LFST) has earned a consensus recommendation of “Moderate Buy” from the nine brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have given a buy rating and two have issued a strong buy rating on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $9.00.

A number of brokerages have weighed in on LFST. Zacks Research downgraded shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. Barclays started coverage on shares of LifeStance Health Group in a report on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 price target for the company. Weiss Ratings restated a “sell (d-)” rating on shares of LifeStance Health Group in a research report on Monday, December 29th. BMO Capital Markets assumed coverage on LifeStance Health Group in a research report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 price objective on the stock. Finally, Wall Street Zen raised LifeStance Health Group from a “hold” rating to a “buy” rating in a research note on Sunday, February 8th.

LifeStance Health Group Stock Performance

LifeStance Health Group stock opened at $7.15 on Friday. The stock has a 50-day simple moving average of $7.11 and a 200 day simple moving average of $6.11. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of -238.33 and a beta of 1.12. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.18. LifeStance Health Group has a 12-month low of $3.74 and a 12-month high of $8.30.

Insider Transactions at LifeStance Health Group

In other news, Director Robert Bessler sold 119,942 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $7.04, for a total value of $844,391.68. Following the transaction, the director owned 1,318,983 shares of the company’s stock, valued at approximately $9,285,640.32. This trade represents a 8.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ann Varanakis sold 50,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $6.90, for a total transaction of $345,000.00. Following the sale, the insider directly owned 315,610 shares of the company’s stock, valued at approximately $2,177,709. This trade represents a 13.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 270,086 shares of company stock valued at $1,891,264. Corporate insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On LifeStance Health Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Larson Financial Group LLC lifted its stake in shares of LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after purchasing an additional 3,791 shares during the period. Bayesian Capital Management LP bought a new stake in LifeStance Health Group in the second quarter valued at about $52,000. Krane Funds Advisors LLC bought a new stake in LifeStance Health Group in the fourth quarter valued at about $71,000. Vanguard Personalized Indexing Management LLC acquired a new position in LifeStance Health Group in the third quarter valued at about $72,000. Finally, Cibc World Markets Corp bought a new position in LifeStance Health Group during the fourth quarter worth about $77,000. 85.50% of the stock is owned by institutional investors.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.